Literature DB >> 26835401

Bringing attention to a need for a standardized treatment and weaning protocol for neonatal abstinence syndrome.

Elisha M Wachman1, Davida M Schiff1.   

Abstract

Entities:  

Year:  2016        PMID： 26835401      PMCID： PMC4729044          DOI： 10.3978/j.issn.2224-4336.2015.12.03

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN： 2224-4336


× No keyword cloud information.
  23 in total

1.  Cohort Analysis of a Pharmacokinetic-Modeled Methadone Weaning Optimization for Neonatal Abstinence Syndrome.

Authors:  Eric S Hall; Jareen Meinzen-Derr; Scott L Wexelblatt
Journal:  J Pediatr       Date:  2015-10-21       Impact factor: 4.406

2.  Variation in treatment of neonatal abstinence syndrome in US children's hospitals, 2004-2011.

Authors:  S W Patrick; H C Kaplan; M Passarella; M M Davis; S A Lorch
Journal:  J Perinatol       Date:  2014-06-12       Impact factor: 2.521

3.  Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting.

Authors:  C H Backes; C R Backes; D Gardner; C A Nankervis; P J Giannone; L Cordero
Journal:  J Perinatol       Date:  2011-08-18       Impact factor: 2.521

4.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Authors:  Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis
Journal:  JAMA       Date:  2012-04-30       Impact factor: 56.272

5.  Formulation of buprenorphine for sublingual use in neonates.

Authors:  Ellena A Anagnostis; Rania E Sadaka; Linda A Sailor; David E Moody; Kevin C Dysart; Walter K Kraft
Journal:  J Pediatr Pharmacol Ther       Date:  2011-10

6.  Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial.

Authors:  Walter K Kraft; Eric Gibson; Kevin Dysart; Vidula S Damle; Jennifer L Larusso; Jay S Greenspan; David E Moody; Karol Kaltenbach; Michelle E Ehrlich
Journal:  Pediatrics       Date:  2008-08-11       Impact factor: 7.124

7.  Variations in opioid receptor genes in neonatal abstinence syndrome.

Authors:  Elisha M Wachman; Marie J Hayes; Richard Sherva; Mark S Brown; Jonathan M Davis; Lindsay A Farrer; David A Nielsen
Journal:  Drug Alcohol Depend       Date:  2015-07-08       Impact factor: 4.492

Review 8.  Neonatal abstinence syndrome.

Authors:  Prabhakar Kocherlakota
Journal:  Pediatrics       Date:  2014-08       Impact factor: 7.124

9.  Neonatal Abstinence Syndrome: Influence of a Combined Inpatient/Outpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population.

Authors:  Jerry Lee; Sonia Hulman; Michael Musci; Ellen Stang
Journal:  Popul Health Manag       Date:  2015-03-24       Impact factor: 2.459

Review 10.  Review of the assessment and management of neonatal abstinence syndrome.

Authors:  Sarah Mary Bagley; Elisha M Wachman; Erica Holland; Susan B Brogly
Journal:  Addict Sci Clin Pract       Date:  2014-09-09
View more
  3 in total

Review 1.  The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.

Authors:  Jason R Pryor; Faouzi I Maalouf; Elizabeth E Krans; Robert E Schumacher; William O Cooper; Stephen W Patrick
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2017-01-10       Impact factor: 5.747

2.  Physiologic Indirect Response Modeling to Describe Buprenorphine Pharmacodynamics in Newborns Treated for Neonatal Opioid Withdrawal Syndrome.

Authors:  Tomoyuki Mizuno; Brooks T McPhail; Suyog Kamatkar; Scott Wexelblatt; Laura Ward; Uwe Christians; Henry T Akinbi; Alexander A Vinks
Journal:  Clin Pharmacokinet       Date:  2021-02       Impact factor: 6.447

Review 3.  Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments.

Authors:  Fei Tang; Chee M Ng; Henrietta S Bada; Markos Leggas
Journal:  Clin Transl Sci       Date:  2021-05-01       Impact factor: 4.689
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.